Drugs / Recombinant bovine basic fibroblast growth factor
Recombinant bovine basic fibroblast growth factor
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03778008 | Dec 2018 → Dec 2019 | stomatitis | Second Affiliated Hospital of Nanchang University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant bovine basic fibroblast growth factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03778008 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant bovine basic fibroblast growth factor is a multifunctional cell growth factor” NCT03778008 ↗ |